Developer docs
API playgroundTry for free, no card

Search company profiles

Tokaora Diagnostics

Full company profile

uuid0008b2m

Namestring
Tokaora Diagnostics
Legal namestring
Tokaora Diagnostics Ltd
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Tokaora Diagnostics Ltd is a privately held New Zealand agritech company founded in late 2021 in Taranaki by Frey Livingston, following his Master of Science research at Victoria University into facial eczema biomarkers. The company is developing a single core product: a rapid diagnostic test (designed in a RAT/lateral-flow format) that detects biomarkers associated with facial eczema — specifically gamma-glutamyltransferase (GGT) and phytoporphyrin — enabling low-cost, on-site detection of the disease in ruminants before clinical signs appear. Facial eczema, caused by the toxin sporidesmin from Pithomyces chartarum spores, is described as causing approximately NZD $250 million in annual losses to New Zealand agriculture through production losses, animal deaths, and welfare impacts, and the company positions its test as the first reliable on-farm rapid diagnostic for a disease that has historically remained 'invisible' until clinical symptoms emerge.

The product is designed to be used by farmers on-farm without laboratory infrastructure, and to function as a tool for veterinarians in their diagnostic kits, supporting pre-purchase screening, end-of-season decisions, and selective management (prevention, breeding, culling) rather than blanket zinc dosing. Tokaora's intended go-to-market is a dual-channel model: primary distribution through livestock veterinarians, complemented by direct farm sales for self-administered testing. The company is pre-revenue and pre-commercial, having concluded its Proof of Concept in 2024 and now seeking additional funding to move into field trials and commercial deployment. To date, Tokaora has been funded entirely by non-dilutive grants from New Zealand government and trust sources — including Callaghan Innovation, AGMARDT, Vernon Willey Trust, MPI Sustainable Food and Fibre Futures, and The Prince's Trust Aotearoa — with no institutional equity investment disclosed.

The company operates with a small, family-led team of approximately four core members (the Livingston family) and draws on expert validation partnerships with Dr Emma Cuttance of Epivets Ltd, Professor Richard Laven of Massey University, and Dr Axel Heiser of AgResearch. No patents, trademarks, or proprietary IP filings have been disclosed, and product pricing has not been publicly set. The current geographic focus is New Zealand only, with the addressable market potentially expanding as facial eczema spreads into the South Island under climate change.

Short descriptiontext

Tokaora Diagnostics is a New Zealand agritech company developing a rapid, on-farm antigen-style diagnostic test for facial eczema in ruminants (cattle and sheep), targeting New Zealand sheep, beef, and dairy farmers and their veterinarians as a pre-commercial, grant-funded venture founded in 2021.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew Plymouth, New Zealand
HQ citystring
New Plymouth
HQ countrystring
New Zealand
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
livestock diagnostic tests, facial eczema testing, ruminant animal health, rapid antigen test kits, veterinary diagnostics
Industry3 codes
PRIMARYHLAHAOAL
Veterinary POCT & Rapid Diagnostics (Animal health rapid tests)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAMADAC
Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYAFACAKAG
Pathogen & Disease Diagnostics Services (Plant, Soil, Water)
Agriculture & Food Production/Agricultural Services (Custom Farming, Agronomy, Veterinary)/Agricultural Testing & Diagnostics Services (Soil, Plant Tissue, Water)
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Livestock Diagnostics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Diagnostic Kit Sales
TypeHardware Sales
Description

Revenue is expected to be generated through the sale of diagnostic kits to veterinarians and directly to farmers. The product is conceived as a commercial off-the-shelf (similar to a RAT test) format, sold per unit. Revenue model type is inferred as one-time / unit-based product sales.

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Tokaora Diagnostics is developing a commercial rapid antigen test (RAT-style kit) that detects facial eczema biomarkers in ruminants at low cost and onsite on the farm. The test enables farmers and veterinarians to identify the disease early, before clinical signs appear, supporting informed management, breeding, and culling decisions. The product targets sheep, beef, and dairy cattle producers in New Zealand and is currently in the prototype/proof-of-concept stage.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Facial eczema costs the New Zealand agricultural economy approximately $250 million per year through production losses, animal deaths, and welfare impacts — representing the addressable problem size.
Product overview1 text field

Tokaora Diagnostics is developing a single core product: the Facial Eczema Rapid Diagnosis Test, a rapid antigen test (RAT) for detecting facial eczema in ruminants. The product is designed for on-farm, low-cost, onsite use by farmers, allowing disease detection without specialized laboratory equipment. The test aims to detect biomarkers (GGT and phytoporphyrin) to enable timely management and treatment decisions. The company is currently in the prototype/Proof of Concept stage with plans to move into field trials and commercial deployment.

Product and service1 record
1Facial Eczema Rapid Diagnosis Test
CategoryLivestock Diagnostics
Description

A commercial rapid antigen test (RAT-style kit) for detecting facial eczema in ruminants (sheep, beef, and dairy cattle). The test detects biomarkers including gamma-glutamyltransferase (GGT) and phytoporphyrin, which accumulate as a result of liver damage caused by the sporidesmin toxin produced by Pithomyces chartarum spores. It is designed for low-cost, onsite use by farmers and veterinarians without requiring specialized laboratory equipment, enabling early disease detection before clinical signs appear and supporting management, pre-purchase, breeding, and culling decisions.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr Emma Cuttance of Epivets Ltd, an expert on facial eczema, provided samples for field testing of Tokaora's diagnostic test. Epivets is a specialist veterinary consultancy providing expertise in facial eczema management.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Professor Richard Laven from Massey University, a recognized expert on facial eczema, has been involved in the project, providing academic expertise and validation support.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr Axel Heiser, Chief Scientist at AgResearch, a Crown Research Institute focused on agricultural science, has been involved in supporting the project.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Tokaora completed the Sprout Agritech Accelerator Cohort IX programme, gaining mentorship, agritech network access, and visibility within the New Zealand agritech ecosystem.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Venture Taranaki awarded Tokaora the Power Up Awards 2022, providing regional recognition and supporting the company's profile within the local innovation community.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global leader in veterinary diagnostics with rapid in-clinic and on-farm livestock test kits (e.g., SNAP, IDEXX Catalyst). Comparable to Tokaora as it sells consumable diagnostic tests used by veterinarians and producers to detect livestock disease biomarkers.

TypeBroad incumbent
Description

Largest global animal health company with a broad diagnostics portfolio including Vetscan rapid tests. Comparable to Tokaora as a scaled incumbent that could enter the on-farm facial eczema diagnostic space as part of its wider livestock diagnostics offering.

TypeDirect peer
Description

Korean-based manufacturer of rapid veterinary diagnostic kits (Anigen brand) for companion animals and livestock. Highly comparable to Tokaora as a focused producer of lateral-flow / rapid antigen tests sold through veterinary channels for animal disease detection.

TypeDirect peer
Description

Veterinary point-of-care diagnostics company (now part of Mars Petcare) producing rapid in-clinic analyzers and tests for livestock and companion animals. Comparable to Tokaora in delivering near-patient, consumable diagnostics to veterinary practitioners.

TypeDirect peer
Description

Austrian manufacturer of veterinary point-of-care analyzers and rapid test kits for livestock and companion animals. Comparable to Tokaora as a smaller-scale specialist in on-site animal health diagnostics sold through vet and farm channels.

TypeDirect peer
Description

Dutch developer and manufacturer of veterinary diagnostic test kits (ELISA, PCR, rapid immunoassays) for poultry, swine, ruminants and aquaculture. Comparable to Tokaora as a livestock-focused rapid diagnostics producer targeting animal health and production.

TypeBroad incumbent
Description

Global life sciences tools and diagnostics company supplying diagnostic reagents, immunoassays and test development platforms. Comparable to Tokaora as a scaled provider of diagnostic substances and IVD technology that could enable or compete with on-farm rapid tests.

TypeBroad incumbent
Description

Major manufacturer of clinical and veterinary diagnostic products, including immunoassay kits and quality controls. Comparable to Tokaora as a scaled incumbent in diagnostic substances with adjacent capability in rapid test development for animal health.

TypeDirect peer
Description

Chinese manufacturer of veterinary diagnostic test kits covering livestock diseases including bovine, swine and poultry pathogens. Comparable to Tokaora as a focused rapid-test kit producer for animal disease biomarkers sold into farming markets.

TypeEmerging player
Description

Diagnostic company with a dedicated veterinary diagnostics portfolio (Evidence range of analyzers and Biochip panels) covering animal health, food and disease screening. Comparable to Tokaora as a diagnostics platform company with animal health applications and a focus on biomarker detection.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tokaora Diagnostics

Livestock Diagnosticstokaoradiagnostics.nz

Tokaora Diagnostics is a New Zealand agritech company developing a rapid, on-farm antigen-style diagnostic test for facial eczema in ruminants (cattle and sheep), targeting New Zealand sheep, beef, and dairy farmers and their veterinarians as a pre-commercial, grant-funded venture founded in 2021.

What Tokaora Diagnostics does

Tokaora Diagnostics Ltd is a privately held New Zealand agritech company founded in late 2021 in Taranaki by Frey Livingston, following his Master of Science research at Victoria University into facial eczema biomarkers. The company is developing a single core product: a rapid diagnostic test (designed in a RAT/lateral-flow format) that detects biomarkers associated with facial eczema — specifically gamma-glutamyltransferase (GGT) and phytoporphyrin — enabling low-cost, on-site detection of the disease in ruminants before clinical signs appear. Facial eczema, caused by the toxin sporidesmin from Pithomyces chartarum spores, is described as causing approximately NZD $250 million in annual losses to New Zealand agriculture through production losses, animal deaths, and welfare impacts, and the company positions its test as the first reliable on-farm rapid diagnostic for a disease that has historically remained 'invisible' until clinical symptoms emerge.

The product is designed to be used by farmers on-farm without laboratory infrastructure, and to function as a tool for veterinarians in their diagnostic kits, supporting pre-purchase screening, end-of-season decisions, and selective management (prevention, breeding, culling) rather than blanket zinc dosing. Tokaora's intended go-to-market is a dual-channel model: primary distribution through livestock veterinarians, complemented by direct farm sales for self-administered testing. The company is pre-revenue and pre-commercial, having concluded its Proof of Concept in 2024 and now seeking additional funding to move into field trials and commercial deployment. To date, Tokaora has been funded entirely by non-dilutive grants from New Zealand government and trust sources — including Callaghan Innovation, AGMARDT, Vernon Willey Trust, MPI Sustainable Food and Fibre Futures, and The Prince's Trust Aotearoa — with no institutional equity investment disclosed.

The company operates with a small, family-led team of approximately four core members (the Livingston family) and draws on expert validation partnerships with Dr Emma Cuttance of Epivets Ltd, Professor Richard Laven of Massey University, and Dr Axel Heiser of AgResearch. No patents, trademarks, or proprietary IP filings have been disclosed, and product pricing has not been publicly set. The current geographic focus is New Zealand only, with the addressable market potentially expanding as facial eczema spreads into the South Island under climate change.

Tokaora Diagnostics firmographics

Firmographics
Name
Tokaora Diagnostics
Legal name
Tokaora Diagnostics Ltd
Website
https://tokaoradiagnostics.nz
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Tokaora Diagnostics is a New Zealand agritech company developing a rapid, on-farm antigen-style diagnostic test for facial eczema in ruminants (cattle and sheep), targeting New Zealand sheep, beef, and dairy farmers and their veterinarians as a pre-commercial, grant-funded venture founded in 2021.
Ownership category
akta.pro rank

Tokaora Diagnostics industry classification

Industry
Product category
Livestock Diagnostics
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAOAL
Veterinary POCT & Rapid Diagnostics (Animal health rapid tests)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAMADAC
Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYAFACAKAG
Pathogen & Disease Diagnostics Services (Plant, Soil, Water)
Agriculture & Food Production/Agricultural Services (Custom Farming, Agronomy, Veterinary)/Agricultural Testing & Diagnostics Services (Soil, Plant Tissue, Water)

Keywords

  • Livestock diagnostic tests
  • Facial eczema testing
  • Ruminant animal health
  • Rapid antigen test kits
  • Veterinary diagnostics

Where Tokaora Diagnostics is headquartered

Location

Headquarters

HQ city
New Plymouth
HQ country
New Zealand
HQ region
Oceania

Offices1 record

Markets served

Tokaora Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain

Revenue model

  1. Diagnostic Kit Sales: Revenue is expected to be generated through the sale of diagnostic kits to veterinarians and directly to farmers. The product is conceived as a commercial off-the-shelf (similar to a RAT test) format, sold per unit. Revenue model type is inferred as one-time / unit-based product sales.

Go-to-market motion2 records

Distribution channels2 records

Tokaora Diagnostics product offering

Product offering

Core offering

Tokaora Diagnostics is developing a commercial rapid antigen test (RAT-style kit) that detects facial eczema biomarkers in ruminants at low cost and onsite on the farm. The test enables farmers and veterinarians to identify the disease early, before clinical signs appear, supporting informed management, breeding, and culling decisions. The product targets sheep, beef, and dairy cattle producers in New Zealand and is currently in the prototype/proof-of-concept stage.

Product overview

Tokaora Diagnostics is developing a single core product: the Facial Eczema Rapid Diagnosis Test, a rapid antigen test (RAT) for detecting facial eczema in ruminants. The product is designed for on-farm, low-cost, onsite use by farmers, allowing disease detection without specialized laboratory equipment. The test aims to detect biomarkers (GGT and phytoporphyrin) to enable timely management and treatment decisions. The company is currently in the prototype/Proof of Concept stage with plans to move into field trials and commercial deployment.

Differentiator

Problem solved

Functional benefit

Products and services

  • Facial Eczema Rapid Diagnosis Test A commercial rapid antigen test (RAT-style kit) for detecting facial eczema in ruminants (sheep, beef, and dairy cattle). The test detects biomarkers including gamma-glutamyltransferase (GGT) and phytoporphyrin, which accumulate as a result of liver damage caused by the sporidesmin toxin produced by Pithomyces chartarum spores. It is designed for low-cost, onsite use by farmers and veterinarians without requiring specialized laboratory equipment, enabling early disease detection before clinical signs appear and supporting management, pre-purchase, breeding, and culling decisions.

Quantifiable outcome

  • Facial eczema costs the New Zealand agricultural economy approximately $250 million per year through production losses, animal deaths, and welfare impacts — representing the addressable problem size.

Companies that use Tokaora Diagnostics

Customer profile

Segments2 records

Ideal customer profiles2 records

Tokaora Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Tokaora Diagnostics partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Epivets LtdcoreStrategic or Co-development PartnerDr Emma Cuttance of Epivets Ltd, an expert on facial eczema, provided samples for field testing of Tokaora's diagnostic test. Epivets is a specialist veterinary consultancy providing expertise in facial eczema management.
  • Massey UniversitycoreStrategic or Co-development PartnerProfessor Richard Laven from Massey University, a recognized expert on facial eczema, has been involved in the project, providing academic expertise and validation support.
  • AgResearchcoreStrategic or Co-development PartnerDr Axel Heiser, Chief Scientist at AgResearch, a Crown Research Institute focused on agricultural science, has been involved in supporting the project.
  • Sprout AcceleratorcoreGTM or Marketing PartnerTokaora completed the Sprout Agritech Accelerator Cohort IX programme, gaining mentorship, agritech network access, and visibility within the New Zealand agritech ecosystem.
  • Venture TaranakiminorGTM or Marketing PartnerVenture Taranaki awarded Tokaora the Power Up Awards 2022, providing regional recognition and supporting the company's profile within the local innovation community.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Tokaora Diagnostics competitors and assessment

Company assessment

Direct peers

  • IDEXX Laboratories: Global leader in veterinary diagnostics with rapid in-clinic and on-farm livestock test kits (e.g., SNAP, IDEXX Catalyst). Comparable to Tokaora as it sells consumable diagnostic tests used by veterinarians and producers to detect livestock disease biomarkers.
  • Bionote: Korean-based manufacturer of rapid veterinary diagnostic kits (Anigen brand) for companion animals and livestock. Highly comparable to Tokaora as a focused producer of lateral-flow / rapid antigen tests sold through veterinary channels for animal disease detection.
  • Heska (Mars Petcare): Veterinary point-of-care diagnostics company (now part of Mars Petcare) producing rapid in-clinic analyzers and tests for livestock and companion animals. Comparable to Tokaora in delivering near-patient, consumable diagnostics to veterinary practitioners.
  • Eurolyser Diagnostica: Austrian manufacturer of veterinary point-of-care analyzers and rapid test kits for livestock and companion animals. Comparable to Tokaora as a smaller-scale specialist in on-site animal health diagnostics sold through vet and farm channels.
  • BioChek: Dutch developer and manufacturer of veterinary diagnostic test kits (ELISA, PCR, rapid immunoassays) for poultry, swine, ruminants and aquaculture. Comparable to Tokaora as a livestock-focused rapid diagnostics producer targeting animal health and production.
  • Ring Biotechnology Co., Ltd. Chinese manufacturer of veterinary diagnostic test kits covering livestock diseases including bovine, swine and poultry pathogens. Comparable to Tokaora as a focused rapid-test kit producer for animal disease biomarkers sold into farming markets.

Broad incumbents

  • Zoetis: Largest global animal health company with a broad diagnostics portfolio including Vetscan rapid tests. Comparable to Tokaora as a scaled incumbent that could enter the on-farm facial eczema diagnostic space as part of its wider livestock diagnostics offering.
  • Thermo Fisher Scientific: Global life sciences tools and diagnostics company supplying diagnostic reagents, immunoassays and test development platforms. Comparable to Tokaora as a scaled provider of diagnostic substances and IVD technology that could enable or compete with on-farm rapid tests.
  • Bio-Rad Laboratories: Major manufacturer of clinical and veterinary diagnostic products, including immunoassay kits and quality controls. Comparable to Tokaora as a scaled incumbent in diagnostic substances with adjacent capability in rapid test development for animal health.

Emerging players

  • Randox: Diagnostic company with a dedicated veterinary diagnostics portfolio (Evidence range of analyzers and Biochip panels) covering animal health, food and disease screening. Comparable to Tokaora as a diagnostics platform company with animal health applications and a focus on biomarker detection.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Tokaora Diagnostics social profiles

Digital presence

Tokaora Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tokaora Diagnostics leadership team

Management profile

Number of profiles

Profiles4 records

Tokaora Diagnostics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tokaora Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tokaora Diagnostics

What does Tokaora Diagnostics do?

Tokaora Diagnostics is developing a commercial rapid antigen test (RAT-style kit) that detects facial eczema biomarkers in ruminants at low cost and onsite on the farm. The test enables farmers and veterinarians to identify the disease early, before clinical signs appear, supporting informed management, breeding, and culling decisions. The product targets sheep, beef, and dairy cattle producers in New Zealand and is currently in the prototype/proof-of-concept stage.

Is Tokaora Diagnostics a public or private company?

Tokaora Diagnostics is a private company. It is classified as family owned and is currently operating.

When was Tokaora Diagnostics founded?

Tokaora Diagnostics was founded in 2021. It employs 1 to 10 people.

Where is Tokaora Diagnostics based?

Tokaora Diagnostics is headquartered in New Plymouth, New Zealand, in the Oceania region.

How does Tokaora Diagnostics make money?

One revenue line is on record: diagnostic Kit Sales.

Who are Tokaora Diagnostics's main competitors?

Direct peers on record are IDEXX Laboratories, Bionote, Heska (Mars Petcare), Eurolyser Diagnostica, BioChek and Ring Biotechnology Co., Ltd.. Broad incumbents are Zoetis, Thermo Fisher Scientific and Bio-Rad Laboratories. Randox is listed as an emerging player.

Does Tokaora Diagnostics have an API?

No public API is recorded for Tokaora Diagnostics.

What industry is Tokaora Diagnostics in?

Tokaora Diagnostics's product category is Livestock Diagnostics. Its primary akta.pro industry code is HLAHAOAL, Veterinary POCT & Rapid Diagnostics (Animal health rapid tests), with a secondary code of HLAMADAC, Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology). Its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales